Genetically engineered antibody-based molecules show enhanced hiv-fighting abilities

29 enero 2015

Capitalizing on a new insight into HIV’s strategy for evading antibodies — proteins produced by the immune system to identify and wipe out invading objects such as viruses — researchers have developed antibody-based molecules that are more than 100 times better than our bodies’ own defenses at binding to and neutralizing HIV, when tested in vitro. The work suggests a novel approach that could be used to engineer more effective HIV-fighting drugs.